Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Recurrent group A Streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant TFH cells.

Dan JM, Havenar-Daughton C, Kendric K, Al-Kolla R, Kaushik K, Rosales SL, Anderson EL, LaRock CN, Vijayanand P, Seumois G, Layfield D, Cutress RI, Ottensmeier CH, Lindestam Arlehamn CS, Sette A, Nizet V, Bothwell M, Brigger M, Crotty S.

Sci Transl Med. 2019 Feb 6;11(478). pii: eaau3776. doi: 10.1126/scitranslmed.aau3776.

PMID:
30728285
2.

Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization.

Banerjee A, Birts CN, Darley M, Parker R, Mirnezami AH, West J, Cutress RI, Beers SA, Rose-Zerilli MJ, Blaydes JP.

Carcinogenesis. 2019 Jan 22. doi: 10.1093/carcin/bgy174. [Epub ahead of print]

PMID:
30668646
3.

Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study.

Potter S, Conroy EJ, Cutress RI, Williamson PR, Whisker L, Thrush S, Skillman J, Barnes NLP, Mylvaganam S, Teasdale E, Jain A, Gardiner MD, Blazeby JM, Holcombe C; iBRA Steering Group; Breast Reconstruction Research Collaborative.

Lancet Oncol. 2019 Feb;20(2):254-266. doi: 10.1016/S1470-2045(18)30781-2. Epub 2019 Jan 9.

4.

Quality of life after breast reconstruction-the BRIOS study.

Potter S, Cutress RI, Conroy EJ, Holcombe C; iBRA Steering Group.

Lancet Oncol. 2018 Nov;19(11):e577. doi: 10.1016/S1470-2045(18)30694-6. Epub 2018 Nov 1. No abstract available.

PMID:
30507480
5.

Opportunities and priorities for breast surgical research.

Cutress RI, McIntosh SA, Potter S, Goyal A, Kirwan CC, Harvey J, Francis A, Carmichael AR, Vidya R, Vaidya JS, Fairbrother P, Benson JR, Reed MWR; Association of Breast Surgery Surgical Gap Analysis Working Group.

Lancet Oncol. 2018 Oct;19(10):e521-e533. doi: 10.1016/S1470-2045(18)30511-4. Epub 2018 Oct 1. Review.

PMID:
30303126
6.

The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective review.

Copson E, Shaaban AM, Maishman T, Moseley PM, McKenzie H, Bradbury J, Borley A, Brzezinska M, Chan SYT, Ching J, Cutress RI, Danial I, Dall B, Kerin M, Lowery AJ, Macpherson IR, Romics L, Sawyer E, Sharmat N, Sircar T, Vidya R, Pan Y, Rea D, Jones L, Eccles DM, Berditchevski F.

Breast. 2018 Dec;42:133-141. doi: 10.1016/j.breast.2018.09.003. Epub 2018 Sep 15.

PMID:
30278369
7.

Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.

Grimmett C, Brooks C, Recio-Saucedo A, Armstrong A, Cutress RI, Gareth Evans D, Copson E, Turner L, Meiser B, Wakefield CE, Eccles D, Foster C.

Support Care Cancer. 2019 Jan;27(1):297-309. doi: 10.1007/s00520-018-4307-x. Epub 2018 Jun 28.

PMID:
29955974
8.

Early breast cancer: why does obesity affect prognosis?

Heetun A, Cutress RI, Copson ER.

Proc Nutr Soc. 2018 Nov;77(4):369-381. doi: 10.1017/S0029665118000447. Epub 2018 Jun 4. Review.

PMID:
29860965
9.

The effects of restricted glycolysis on stem-cell like characteristics of breast cancer cells.

Banerjee A, Arvinrad P, Darley M, Laversin SA, Parker R, Rose-Zerilli MJJ, Townsend PA, Cutress RI, Beers SA, Houghton FD, Birts CN, Blaydes JP.

Oncotarget. 2018 May 1;9(33):23274-23288. doi: 10.18632/oncotarget.25299. eCollection 2018 May 1.

10.

Mastectomy skin flap thickness.

Robertson SA, Cutress RI.

Eur J Surg Oncol. 2018 Jul;44(7):1118. doi: 10.1016/j.ejso.2018.03.034. Epub 2018 Apr 22. No abstract available.

PMID:
29724632
11.

Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.

Zeidan B, Manousopoulou A, Garay-Baquero DJ, White CH, Larkin SET, Potter KN, Roumeliotis TI, Papachristou EK, Copson E, Cutress RI, Beers SA, Eccles D, Townsend PA, Garbis SD.

Breast Cancer Res. 2018 Mar 22;20(1):19. doi: 10.1186/s13058-018-0938-6.

12.

Reply to 'Comment on 'BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses''.

Papadakis ES, Reeves T, Robson NH, Maishman T, Packham G, Cutress RI.

Br J Cancer. 2018 Apr;118(8):1154. doi: 10.1038/s41416-018-0032-y. Epub 2018 Mar 15. No abstract available.

PMID:
29540772
13.

Adherence to best practice consensus guidelines for implant-based breast reconstruction: Results from the iBRA national practice questionnaire survey.

Mylvaganam S, Conroy EJ, Williamson PR, Barnes NLP, Cutress RI, Gardiner MD, Jain A, Skillman JM, Thrush S, Whisker LJ, Blazeby JM, Potter S, Holcombe C; iBRA Steering Group; Breast Reconstruction Research Collaborative.

Eur J Surg Oncol. 2018 May;44(5):708-716. doi: 10.1016/j.ejso.2018.01.098. Epub 2018 Feb 7.

14.

"It's Like We Don't Exist": Tailoring Education for Young Women Undergoing Surgery for Early-Stage Breast Cancer

Recio-Saucedo A, Gilbert AW, Gerty S, Cutress RI, Eccles D, Foster C.

Oncol Nurs Forum. 2018 Mar 1;45(2):165-175. doi: 10.1188/18.ONF.165-175.

PMID:
29466349
15.

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.

Copson ER, Maishman TC, Tapper WJ, Cutress RI, Greville-Heygate S, Altman DG, Eccles B, Gerty S, Durcan LT, Jones L, Evans DG, Thompson AM, Pharoah P, Easton DF, Dunning AM, Hanby A, Lakhani S, Eeles R, Gilbert FJ, Hamed H, Hodgson S, Simmonds P, Stanton L, Eccles DM.

Lancet Oncol. 2018 Feb;19(2):169-180. doi: 10.1016/S1470-2045(17)30891-4. Epub 2018 Jan 11.

16.

Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancer.

Grimmett C, Pickett K, Shepherd J, Welch K, Recio-Saucedo A, Streit E, Seers H, Armstrong A, Cutress RI, Evans DG, Copson E, Meiser B, Eccles D, Foster C.

Patient Educ Couns. 2018 May;101(5):779-788. doi: 10.1016/j.pec.2017.11.016. Epub 2017 Nov 26. Review.

PMID:
29225062
17.

Variation in the provision and practice of implant-based breast reconstruction in the UK: Results from the iBRA national practice questionnaire.

Mylvaganam S, Conroy E, Williamson PR, Barnes NLP, Cutress RI, Gardiner MD, Jain A, Skillman JM, Thrush S, Whisker LJ, Blazeby JM, Potter S, Holcombe C; iBRA Steering Group; Breast Reconstruction Research Collaborative.

Breast. 2017 Oct;35:182-190. doi: 10.1016/j.breast.2017.07.016. Epub 2017 Jul 30.

18.

BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses.

Papadakis ES, Reeves T, Robson NH, Maishman T, Packham G, Cutress RI.

Br J Cancer. 2017 Jun 6;116(12):1585-1594. doi: 10.1038/bjc.2017.130. Epub 2017 May 16. Review.

19.

Mastectomy skin flap necrosis: challenges and solutions.

Robertson SA, Jeevaratnam JA, Agrawal A, Cutress RI.

Breast Cancer (Dove Med Press). 2017 Mar 13;9:141-152. doi: 10.2147/BCTT.S81712. eCollection 2017. Review.

20.

The iBRA (implant breast reconstruction evaluation) study: protocol for a prospective multi-centre cohort study to inform the feasibility, design and conduct of a pragmatic randomised clinical trial comparing new techniques of implant-based breast reconstruction.

Potter S, Conroy EJ, Williamson PR, Thrush S, Whisker LJ, Skillman JM, Barnes NL, Cutress RI, Teasdale EM, Mills N, Mylvaganam S, Branford OA, McEvoy K, Jain A, Gardiner MD, Blazeby JM, Holcombe C; Breast Reconstruction Research Collaborative.

Pilot Feasibility Stud. 2016 Aug 4;2:41. eCollection 2016.

21.

How to Manage the Obese Patient With Cancer.

Renehan AG, Harvie M, Cutress RI, Leitzmann M, Pischon T, Howell S, Howell A.

J Clin Oncol. 2016 Dec 10;34(35):4284-4294. Epub 2016 Nov 7. Review.

PMID:
27903151
22.

Radiopathological features predictive of involved margins in ductal carcinoma in situ.

Layfield DM, See H, Stahnke M, Hayward L, Cutress RI, Oeppen RS.

Ann R Coll Surg Engl. 2017 Feb;99(2):137-144. doi: 10.1308/rcsann.2016.0299. Epub 2016 Sep 23.

23.

Regulation of osteoblast development by Bcl-2-associated athanogene-1 (BAG-1).

Greenhough J, Papadakis ES, Cutress RI, Townsend PA, Oreffo RO, Tare RS.

Sci Rep. 2016 Sep 16;6:33504. doi: 10.1038/srep33504.

24.

Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study.

Maishman T, Cutress RI, Hernandez A, Gerty S, Copson ER, Durcan L, Eccles DM.

Ann Surg. 2017 Jul;266(1):165-172. doi: 10.1097/SLA.0000000000001930.

25.

Evaluation of the Metasin assay for intraoperative assessment of sentinel lymph node metastases in breast cancer.

Smith GJ, Hodges E, Markham H, Zhang S, Cutress RI.

J Clin Pathol. 2017 Feb;70(2):134-139. doi: 10.1136/jclinpath-2016-203728. Epub 2016 Jul 12.

PMID:
27406050
26.

The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ.

Papadakis ES, Barker CR, Syed H, Reeves T, Schwaiger S, Stuppner H, Troppmair J, Blaydes JP, Cutress RI.

Oncogenesis. 2016 Apr 4;5:e215. doi: 10.1038/oncsis.2016.10.

27.

Information requirements of young women with breast cancer treated with mastectomy or breast conserving surgery: A systematic review.

Recio-Saucedo A, Gerty S, Foster C, Eccles D, Cutress RI.

Breast. 2016 Feb;25:1-13. doi: 10.1016/j.breast.2015.11.001. Epub 2015 Nov 30. Review.

PMID:
26801410
28.

Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target.

Zeidan B, Jackson TR, Larkin SE, Cutress RI, Coulton GR, Ashton-Key M, Murray N, Packham G, Gorgoulis V, Garbis SD, Townsend PA.

Oncotarget. 2015 Aug 28;6(25):21421-7.

29.

Family history and outcome of young patients with breast cancer in the UK (POSH study).

Eccles BK, Copson ER, Cutress RI, Maishman T, Altman DG, Simmonds P, Gerty SM, Durcan L, Stanton L, Eccles DM; POSH Study Steering Group.

Br J Surg. 2015 Jul;102(8):924-35. doi: 10.1002/bjs.9816. Epub 2015 May 20.

PMID:
25989914
30.

Obesity in breast cancer--what is the risk factor?

James FR, Wootton S, Jackson A, Wiseman M, Copson ER, Cutress RI.

Eur J Cancer. 2015 Apr;51(6):705-20. doi: 10.1016/j.ejca.2015.01.057. Epub 2015 Mar 3. Review.

PMID:
25747851
31.

Clinical proteomics and breast cancer.

Zeidan BA, Townsend PA, Garbis SD, Copson E, Cutress RI.

Surgeon. 2015 Oct;13(5):271-8. doi: 10.1016/j.surge.2014.12.003. Epub 2015 Feb 24. Review.

PMID:
25736469
32.

Obesity and the outcome of young breast cancer patients in the UK: the POSH study.

Copson ER, Cutress RI, Maishman T, Eccles BK, Gerty S, Stanton L, Altman DG, Durcan L, Wong C, Simmonds PD, Jones L, Eccles DM; POSH Study Steering Group.

Ann Oncol. 2015 Jan;26(1):101-12. doi: 10.1093/annonc/mdu509. Epub 2014 Oct 30.

PMID:
25361993
33.

Oncoplastic breast conserving surgery.

Mansfield L, Agrawal A, Cutress RI.

Gland Surg. 2013 Aug;2(3):158-62. doi: 10.3978/j.issn.2227-684X.2013.08.04. Review.

34.

Determinants of optimal mastectomy skin flap thickness.

Robertson SA, Rusby JE, Cutress RI.

Br J Surg. 2014 Jul;101(8):899-911. doi: 10.1002/bjs.9470. Epub 2014 Mar 24. Review.

PMID:
24664617
35.

Tumour grade on core biopsy and evidence of axillary involvement on ultrasound predicts response in elderly co-morbid patients treated with primary hormone therapy for oestrogen receptor positive breast carcinoma.

Layfield DM, Mohamud M, Odofin O, Walsh C, Royle GT, Cutress RI.

Surgeon. 2015 Apr;13(2):61-8. doi: 10.1016/j.surge.2013.11.021. Epub 2014 Jan 9.

PMID:
24411703
36.

Staging Investigations in Breast Cancer: Collective Opinion of UK Breast Surgeons.

Chand N, Cutress RI, Oeppen RS, Agrawal A.

Int J Breast Cancer. 2013;2013:506172. doi: 10.1155/2013/506172. Epub 2013 Nov 20.

37.

Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study.

Copson E, Maishman T, Gerty S, Eccles B, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Jones L, Tapper W; POSH study steering group, Eccles D.

Br J Cancer. 2014 Jan 7;110(1):230-41. doi: 10.1038/bjc.2013.650. Epub 2013 Oct 22.

38.

Isolation of a novel thioflavin S-derived compound that inhibits BAG-1-mediated protein interactions and targets BRAF inhibitor-resistant cell lines.

Enthammer M, Papadakis ES, Salomé Gachet M, Deutsch M, Schwaiger S, Koziel K, Ashraf MI, Khalid S, Wolber G, Packham G, Cutress RI, Stuppner H, Troppmair J.

Mol Cancer Ther. 2013 Nov;12(11):2400-14. doi: 10.1158/1535-7163.MCT-13-0142. Epub 2013 Sep 18.

39.

Guidelines for oncoplastic breast reconstruction.

Cutress RI, Summerhayes C, Rainsbury R.

Ann R Coll Surg Engl. 2013 Apr;95(3):161-2. doi: 10.1308/003588413X13511609957696. No abstract available.

40.

Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.

Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Lawrence G, Jones L, Bliss J, Eccles D; POSH Study Steering Group.

J Natl Cancer Inst. 2013 Jul 3;105(13):978-88. doi: 10.1093/jnci/djt134. Epub 2013 May 30.

PMID:
23723422
41.

Repeat surgery following breast conservation and intra-operative sentinel lymph node analysis for breast cancer.

Dabbas N, Cutress RI, Wise M, Yiangou C, Agrawal A.

Surgeon. 2013 Oct;11(5):235-40. doi: 10.1016/j.surge.2012.12.008. Epub 2013 Feb 28.

PMID:
23453370
42.

Modification of the Wise pattern breast reduction for oncological mammaplasty of upper outer and upper inner quadrant breast tumours: a technical note and case series.

Cutress RI, Simoes T, Gill J, Hurren JS.

J Plast Reconstr Aesthet Surg. 2013 Feb;66(2):e31-6. doi: 10.1016/j.bjps.2012.09.003. Epub 2012 Oct 3. Review.

PMID:
23040409
43.

The axillary nodal harvest in breast cancer surgery is unchanged by sentinel node biopsy or the timing of surgery.

Byrne BE, Cutress RI, Gill J, Wise MH, Yiangou C, Agrawal A.

Int J Breast Cancer. 2012;2012:467825. doi: 10.1155/2012/467825. Epub 2012 May 30.

44.

Rupture of breast implant shell must be differentiated from gel bleed.

Boffa C, Cutress RI, Rubin CM, Horlock N, Royle GT.

BMJ. 2012 May 1;344:e2574. doi: 10.1136/bmj.e2574. No abstract available.

PMID:
22549053
45.

The effect of introducing an in-theatre intra-operative specimen radiography (IOSR) system on the management of palpable breast cancer within a single unit.

Layfield DM, May DJ, Cutress RI, Richardson C, Agrawal A, Wise M, Yiangou C.

Breast. 2012 Aug;21(4):459-63. doi: 10.1016/j.breast.2011.10.010. Epub 2011 Nov 25.

PMID:
22119488
46.

The influence of clinicopathological features on the predictive accuracy of conventional breast imaging in determining the extent of screen-detected high-grade pure ductal carcinoma in situ.

Hayward L, Oeppen RS, Grima AV, Royle GT, Rubin CM, Cutress RI.

Ann R Coll Surg Engl. 2011 Jul;93(5):385-90. doi: 10.1308/003588411X579829.

47.

Letter to the editor relating to the editorial EJSO 36 (2010) 1162-1164.

Cutress RI, Agrawal A, Layer GT.

Eur J Surg Oncol. 2011 May;37(5):452; author reply 453. doi: 10.1016/j.ejso.2011.01.020. No abstract available.

PMID:
21316186
48.

Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.

Birts CN, Harding R, Soosaipillai G, Halder T, Azim-Araghi A, Darley M, Cutress RI, Bateman AC, Blaydes JP.

Biol Cell. 2010 Jan;103(1):1-19. doi: 10.1042/BC20100067.

49.

Intraoperative assessment of sentinel lymph nodes in breast cancer.

Layfield DM, Agrawal A, Roche H, Cutress RI.

Br J Surg. 2011 Jan;98(1):4-17. doi: 10.1002/bjs.7229. Epub 2010 Sep 1. Review.

PMID:
20812233
50.

Patient satisfaction following nipple-areolar complex reconstruction and tattooing.

Goh SC, Martin NA, Pandya AN, Cutress RI.

J Plast Reconstr Aesthet Surg. 2011 Mar;64(3):360-3. doi: 10.1016/j.bjps.2010.05.010. Epub 2010 Jun 8.

PMID:
20570584

Supplemental Content

Loading ...
Support Center